Although no obvious glioma cells were identified, immunohistochemistry (IHC) for the canonical isocitrate dehydrogenase 1 (IDH1) R132H mutation revealed unequivocally positive cells with long, ramified processes (Figure 2B and C). This evidence concerns the gene IDH1 and central nervous system cancer.